Medicament for treating prostatic diseases
Patent Information
- Authority / Receiving Office
- CN Β· China
- Current Assignee / Owner
- TIAYUAN SAI & SCI & TECH DEVCO
- Publication Date
- 2008-12-17
- Estimated Expiration
- Not applicable Β· inactive patent
Abstract
Description
technical field
[0001] The invention belongs to the technical field of traditional Chinese medicines, in particular to a medicine for treating male prostate diseases. Background technique
[0002] Benign prostatic hyperplasia (BPH) is one of the common diseases among elderly men. The incidence rate of men over 70 years old is more than 70%, which seriously affects the quality of life of elderly men. It has become one of the main contents of domestic and foreign research.
[0003] Drug treatment for BPH mainly includes androgen, estrogen or a combination of male and female hormones; Ξ±-adrenoceptor blockers represented by phenoxybenzamine; antiandrogen drugs, such as Proscar, but these drugs have long-term It is found in the clinical application of many drugs that they cannot obviously alleviate the clinical symptoms caused by BPH, and even have many side effects on the human body. Therefore, the research on efficient and non-toxic drugs has broad prospects and important app...